At the 31st Japanese Society of Transfusion Medicine and Cell Therapy (date: October 18-19, 2024, venue: Sonic City), Professor Toshio Miyata of the Tohoku University Graduate School of Medicine (Chairman of the Board of Directors of our company) gave a special lecture on “Clinical Applications of PAI-1 Inhibitors.” He spoke about the unexpected roles of PAI-1 in cancer and aging, and the status of research and development of PAI-1 inhibitors as the novel treatment for these diseases.